Alpha-Mangostin: A Potent Inhibitor of TRPV3 and Pro-Inflammatory Cytokine Secretion in Keratinocytes.
TRPV3
alpha-mangostin
dermatitis
keratinocytes
skin inflammation
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
18 Aug 2023
18 Aug 2023
Historique:
received:
04
08
2023
revised:
14
08
2023
accepted:
17
08
2023
medline:
28
8
2023
pubmed:
26
8
2023
entrez:
26
8
2023
Statut:
epublish
Résumé
The TRPV3 calcium ion channel is vital for maintaining skin health and has been associated with various skin-related disorders. Since TRPV3 is involved in the development of skin inflammation, inhibiting TRPV3 could be a potential treatment strategy. Alpha-mangostin isolated from
Identifiants
pubmed: 37629111
pii: ijms241612930
doi: 10.3390/ijms241612930
pmc: PMC10455244
pii:
doi:
Substances chimiques
mangostin
U6RIV93RU1
Cytokines
0
TRPV3 protein, human
0
TRPV Cation Channels
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : National Research Foundation of Korea
ID : NRF-2021R1A6A1A03038865
Organisme : Korea Health Industry Development Institute
ID : HP20C0199
Pays : Republic of Korea
Organisme : Dongguk University WISE
ID : Researh Fund 2023
Références
Am J Chin Med. 2018;46(5):1079-1092
pubmed: 29976084
J Invest Dermatol. 2018 Feb;138(2):365-374
pubmed: 28964718
J Microsc. 2018 Mar;269(3):212-220
pubmed: 28837217
J Invest Dermatol. 2012 Aug;132(8):2109-12
pubmed: 22475759
Br J Pharmacol. 2021 Apr;178(7):1669-1683
pubmed: 33501656
J Invest Dermatol. 2009 Mar;129(3):714-22
pubmed: 18754035
Mol Pharmacol. 2019 Sep;96(3):393-400
pubmed: 31308264
Acta Pharm Sin B. 2022 Feb;12(2):723-734
pubmed: 35256942
Cell Biol Toxicol. 2021 Apr;37(2):313-330
pubmed: 32535744
Food Funct. 2018 Jul 17;9(7):3860-3871
pubmed: 29953154
Exp Dermatol. 2013 Jul;22(7):447-52
pubmed: 23800054
J Allergy Clin Immunol. 2021 Mar;147(3):1110-1114.e5
pubmed: 33035568
Phytomedicine. 2023 Jul;115:154791
pubmed: 37094425
Bio Protoc. 2017 Jul 20;7(14):e2411
pubmed: 34541141
J Dermatol Sci. 2020 Mar;97(3):229-231
pubmed: 31983608
Curr Top Membr. 2014;74:325-64
pubmed: 25366242
Cell. 2010 Apr 16;141(2):331-43
pubmed: 20403327
Nat Neurosci. 2006 May;9(5):628-35
pubmed: 16617338
Int J Mol Sci. 2022 Nov 29;23(23):
pubmed: 36499288
Ann Dermatol. 2018 Jun;30(3):265-275
pubmed: 29853739
J Pharmacol Exp Ther. 2019 Jan;368(1):21-31
pubmed: 30377214
Neurosci Bull. 2018 Feb;34(1):120-142
pubmed: 29282613
Korean J Physiol Pharmacol. 2021 Jan 1;25(1):87-94
pubmed: 33361541
Korean J Physiol Pharmacol. 2018 Nov;22(6):697-703
pubmed: 30402030
J Invest Dermatol. 2012 Apr;132(4):1253-62
pubmed: 22189789
J Invest Dermatol. 2020 Aug;140(8):1524-1532
pubmed: 32004565
Front Immunol. 2022 Apr 07;13:801579
pubmed: 35464457
J Invest Dermatol. 1993 Nov;101(5):690-4
pubmed: 8228330
J Dermatol. 2013 Oct;40(10):786-96
pubmed: 24033377
Am J Hum Genet. 2012 Mar 9;90(3):558-64
pubmed: 22405088
Pharm Biol. 2017 Dec;55(1):1324-1329
pubmed: 28290212
J Allergy Clin Immunol. 2006 Feb;117(2):411-7
pubmed: 16461142
Immunopharmacol Immunotoxicol. 2018 Oct;40(5):415-422
pubmed: 30422030
Mol Pharmacol. 2018 Oct;94(4):1164-1173
pubmed: 30108138
Metabolites. 2012 Apr 16;2(2):303-36
pubmed: 24957513
Molecules. 2023 Jan 12;28(2):
pubmed: 36677834
Nat Prod Commun. 2013 Sep;8(9):1229-32
pubmed: 24273853
Int J Mol Sci. 2018 May 25;19(6):
pubmed: 29799486
Mar Drugs. 2017 Mar 23;15(4):
pubmed: 28333079
J Pharmacol Sci. 2015 Dec;129(4):226-32
pubmed: 26701606
Biochem Biophys Rep. 2021 Feb 15;26:100949
pubmed: 33665379
Nat Struct Mol Biol. 2019 Nov;26(11):994-998
pubmed: 31636415
J Invest Dermatol. 2006 Dec;126(12):2664-72
pubmed: 16858425
Sci Rep. 2016 May 10;6:25657
pubmed: 27160770
FASEB J. 2015 Jan;29(1):182-92
pubmed: 25351988
J Invest Dermatol. 2011 Aug;131(8):1605-14
pubmed: 21593771